Literature DB >> 26365583

Pancreatic pathophysiology in cystic fibrosis.

Katherine N Gibson-Corley1, David K Meyerholz1, John F Engelhardt2.   

Abstract

The pancreas is one of the earliest, and most commonly affected, organs in patients with cystic fibrosis (CF). Studying the pathogenesis of pancreatic disease is limited in CF patients, due to its early clinical onset, co-morbidities and lack of tissue samples from the early phases of disease. In recent years, several new CF animal models have been developed that have advanced our understanding of both CF exocrine and endocrine pancreatic disease. Additionally, these models have helped us to better define the influence of pancreatic lesions on CF disease progression in other organs, such as the gastrointestinal tract and lung.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  cystic fibrosis; cystic fibrosis transmembrane conductance regulator; diabetes; pancreas; pancreatic insufficiency; pathology

Mesh:

Year:  2015        PMID: 26365583      PMCID: PMC4699289          DOI: 10.1002/path.4634

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  104 in total

Review 1.  Recent trends in cystic fibrosis-related diabetes.

Authors:  Brandon M Nathan; Theresa Laguna; Antoinette Moran
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-08       Impact factor: 3.243

2.  Glucose tolerance in cystic fibrosis.

Authors:  S Lanng; B Thorsteinsson; G Erichsen; J Nerup; C Koch
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

Review 3.  No potassium, no acid: K+ channels and gastric acid secretion.

Authors:  Dirk Heitzmann; Richard Warth
Journal:  Physiology (Bethesda)       Date:  2007-10

4.  Transepithelial bicarbonate secretion: lessons from the pancreas.

Authors:  Hyun Woo Park; Min Goo Lee
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

5.  Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways.

Authors:  Maisam Abu-El-Haija; Shyam Ramachandran; David K Meyerholz; Marwa Abu-El-Haija; Michelle Griffin; Radhamma L Giriyappa; David A Stoltz; Michael J Welsh; Paul B McCray; Aliye Uc
Journal:  Am J Pathol       Date:  2012-06-08       Impact factor: 4.307

6.  The characterization of the first anti-mouse Muc6 antibody shows an increased expression of the mucin in pancreatic tissue of Cftr-knockout mice.

Authors:  Valérie Gouyer; Shih-Hsing Leir; Daniel Tetaert; Yamin Liu; Frédéric Gottrand; Ann Harris; Jean-Luc Desseyn
Journal:  Histochem Cell Biol       Date:  2010-03-23       Impact factor: 4.304

7.  Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.

Authors:  William R Hunt; Susu M Zughaier; Dana E Guentert; Melissa A Shenep; Michael Koval; Nael A McCarty; Jason M Hansen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-04       Impact factor: 5.464

Review 8.  Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.

Authors:  James L Kreindler
Journal:  Pharmacol Ther       Date:  2009-11-10       Impact factor: 12.310

9.  Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study.

Authors:  M Löhr; P Goertchen; H Nizze; N S Gould; V E Gould; M Oberholzer; P U Heitz; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

10.  Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.

Authors:  Peter R Durie; Geraldine Kent; M James Phillips; Cameron A Ackerley
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

View more
  29 in total

Review 1.  Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target.

Authors:  Thiago Inácio Teixeira do Carmo; Victor Emanuel Miranda Soares; Jonatha Wruck; Fernanda Dos Anjos; Débora Tavares de Resende E Silva; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini
Journal:  Inflamm Res       Date:  2021-04-27       Impact factor: 4.575

2.  Prospective, Randomized, Double-Blind, Parallel-Group, Comparative Effectiveness Clinical Trial Comparing a Powder Vehicle Compound of Vitamin D With an Oil Vehicle Compound in Adults With Cystic Fibrosis.

Authors:  Wendy A Hermes; Jessica A Alvarez; Moon J Lee; Supavit Chesdachai; Daud Lodin; Ron Horst; Vin Tangpricha
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-02-22       Impact factor: 4.016

3.  Pancreatic and Islet Remodeling in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Knockout Ferrets.

Authors:  Pavana G Rotti; Weiliang Xie; Ananta Poudel; Yaling Yi; Xingshen Sun; Scott R Tyler; Aliye Uc; Andrew W Norris; Manami Hara; John F Engelhardt; Katherine N Gibson-Corley
Journal:  Am J Pathol       Date:  2018-01-31       Impact factor: 4.307

Review 4.  Total pancreatectomy for recurrent acute and chronic pancreatitis: a critical review of patient selection criteria.

Authors:  Mahya Faghih; Francisco Garcia Gonzalez; Martin A Makary; Vikesh K Singh
Journal:  Curr Opin Gastroenterol       Date:  2017-09       Impact factor: 3.287

5.  Cystic fibrosis-related diabetes is caused by islet loss and inflammation.

Authors:  Nathaniel J Hart; Radhika Aramandla; Gregory Poffenberger; Cody Fayolle; Ariel H Thames; Austin Bautista; Aliya F Spigelman; Jenny Aurielle B Babon; Megan E DeNicola; Prasanna K Dadi; William S Bush; Appakalai N Balamurugan; Marcela Brissova; Chunhua Dai; Nripesh Prasad; Rita Bottino; David A Jacobson; Mitchell L Drumm; Sally C Kent; Patrick E MacDonald; Alvin C Powers
Journal:  JCI Insight       Date:  2018-04-19

Review 6.  Lessons learned from the cystic fibrosis pig.

Authors:  David K Meyerholz
Journal:  Theriogenology       Date:  2016-04-21       Impact factor: 2.740

Review 7.  Dental treatment for people with cystic fibrosis.

Authors:  N Harrington; P J Barry; S M Barry
Journal:  Eur Arch Paediatr Dent       Date:  2016-05-04

8.  Interpreting type 1 diabetes risk with genetics and single-cell epigenomics.

Authors:  Joshua Chiou; Ryan J Geusz; Mei-Lin Okino; Jee Yun Han; Michael Miller; Rebecca Melton; Elisha Beebe; Paola Benaglio; Serina Huang; Katha Korgaonkar; Sandra Heller; Alexander Kleger; Sebastian Preissl; David U Gorkin; Maike Sander; Kyle J Gaulton
Journal:  Nature       Date:  2021-05-19       Impact factor: 49.962

9.  Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.

Authors:  Yu-Chung Lin; Katherine Keenan; Jiafen Gong; Naim Panjwani; Julie Avolio; Fan Lin; Damien Adam; Paula Barrett; Stéphanie Bégin; Yves Berthiaume; Lara Bilodeau; Candice Bjornson; Janna Brusky; Caroline Burgess; Mark Chilvers; Raquel Consunji-Araneta; Guillaume Côté-Maurais; Andrea Dale; Christine Donnelly; Lori Fairservice; Katie Griffin; Natalie Henderson; Angela Hillaby; Daniel Hughes; Shaikh Iqbal; Jennifer Itterman; Mary Jackson; Emma Karlsen; Lorna Kosteniuk; Lynda Lazosky; Winnie Leung; Valerie Levesque; Émilie Maille; Dimas Mateos-Corral; Vanessa McMahon; Mays Merjaneh; Nancy Morrison; Michael Parkins; Jennifer Pike; April Price; Bradley S Quon; Joe Reisman; Clare Smith; Mary Jane Smith; Nathalie Vadeboncoeur; Danny Veniott; Terry Viczko; Pearce Wilcox; Richard van Wylick; Garry Cutting; Elizabeth Tullis; Felix Ratjen; Johanna M Rommens; Lei Sun; Melinda Solomon; Anne L Stephenson; Emmanuelle Brochiero; Scott Blackman; Harriet Corvol; Lisa J Strug
Journal:  Genet Med       Date:  2021-01-26       Impact factor: 8.822

10.  Persistent Cannabis Abuse and Risk for Hospitalization for Acute Pancreatitis: A Cross-Sectional Study in United States Hospitals.

Authors:  Renu Bhandari; Siddharth Gupta; Karnav Modi; Maharshi R Raval; Hajara Joundi; Jeet R Patel; Amanpreet K Pannu; Prerna Sharma
Journal:  Cureus       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.